Tulissin® 100 Injectable Solution isn’t just for Bovine Respiratory Disease (BRD)
Reach for it in the face of Infectious Bovine Keratoconjunctivitis (IBK), more commonly known as pinkeye, when associated with Moraxella Bovis. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows.
Tulissin® 100 Injectable Solution is also indicated for bovine foot rot (interdigital necrobacillosis) associated with either Fusobacterium necrophorum and Porphyromonas levii. Note that Tulissin® 100 Injectable Solution is contraindicated in animals previously found to be hypersensitive to the drug.
But when you do have BRD, Tulissin 100 injectable solution is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus
somni, and Mycoplasma bovis.
Foot Rot - Tulissin® 100 Injectable Solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii. Suckling Calves, Dairy Calves, and Veal Calves.
BRD - Tulissin® 100 Injectable Solution is indicated for the treatment of BRD associated with M. haemolytica, P. multocida, H. somni, and M. bovis.
Swine - Tulissin® 100 Injectable Solution is indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis, and Mycoplasma hyopneumoniae; and for the control of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed.
TULISSIN® 100 (tulathromycin injection): Not for use in humans. Ensure a pre-slaughter withdrawal time of eighteen (18) days in cattle. Do not use in dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. The effects of tulathromycin on bovine reproductive performance, pregnancy and lactation have not been determined. Do not use in animals known to be hypersensitive to the product. Download the prescribing information here.
TULISSIN® 25 (tulathromycin injection): Not for use in ruminating cattle. Ensure a pre-slaughter withdrawal time of twenty-two (22) days in calves and five (5) days in swine. The effects of tulathromycin on bovine and swine reproductive performance, pregnancy and lactation have not been determined. Do not use in animals known to be hypersensitive to the product.
Reference:
1 - Patent application n°WO2019201812 Registered international design n°DM/103483. 2 - Internal study. 3 - Darcq S, Steiner A, Jarrin D, Newberry J, Durel L. An innovative shock-absorbing blue silicone shell to reduce breakage of veterinary pharmaceutical glass vials. 2022. International Journal of Science and Technology Research. 04(01), 018-025
This website uses cookies necessary for the proper functioning of the site and to facilitate your navigation. You will find more information about cookies, how we use them and how you can control their use by clicking on the following link: Cookies. By continuing your visit to this site, you agree that we use cookies, as specified in our policy.
